These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 23696942)
1. Successful treatment with recombinant thrombomodulin for B-cell lymphoma-associated hemophagocytic syndrome complicated by disseminated intravascular coagulation. Uni M; Yoshimi A; Maki H; Maeda D; Nakazaki K; Nakamura F; Fukayama M; Kurokawa M Int J Clin Exp Pathol; 2013; 6(6):1190-4. PubMed ID: 23696942 [TBL] [Abstract][Full Text] [Related]
2. [Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome]. Yamazaki H; Kondo T; Tatsumi G; Kotani S; Arai Y; Shirakawa K; Kitano T; Hishizawa M; Kadowaki N; Takaori-Kondo A Rinsho Ketsueki; 2015 Mar; 56(3):312-6. PubMed ID: 25876785 [TBL] [Abstract][Full Text] [Related]
3. [Adult T-cell leukemia-lymphoma developed from an HTLV-1 carrier during treatment of B-cell lymphoma-associated hemophagocytic syndrome]. Nagao T; Takahashi N; Saitoh H; Noguchi S; Guo YM; Ito M; Watanabe A; Fujishima N; Kameoka Y; Tagawa H; Hirokawa M; Sawada K Rinsho Ketsueki; 2012 Dec; 53(12):2008-12. PubMed ID: 23318967 [TBL] [Abstract][Full Text] [Related]
4. Recombinant human soluble thrombomodulin is active against hemophagocytic lymphohistiocytosis associated with acquired immunodeficiency syndrome. Chi S; Ikezoe T; Takeuchi A; Takaoka M; Yokoyama A Int J Hematol; 2013 Nov; 98(5):615-9. PubMed ID: 24101336 [TBL] [Abstract][Full Text] [Related]
5. Use of recombinant thrombomodulin in disseminated intravascular coagulation complicated hemophagocytic lymphohistiocytosis. Yamamoto M; Hori T; Hatakeyama N; Igarashi K; Inazawa N; Tsutsumi H; Suzuki N Indian J Pediatr; 2014 Mar; 81(3):288-91. PubMed ID: 23912823 [TBL] [Abstract][Full Text] [Related]
6. TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin. Takayama Y; Kubota T; Ogino Y; Ohnishi H; Togitani K; Yokoyama A Intern Med; 2018 May; 57(9):1291-1296. PubMed ID: 29279488 [TBL] [Abstract][Full Text] [Related]
7. Multicenter clinical experience with recombinant soluble thrombomodulin for disseminated intravascular coagulation associated with severe acute cholecystitis. Ogura T; Eguchi T; Amano M; Sano T; Nishioka N; Miyano A; Tsujimae M; Tanimura H; Yamada T; Terashima Y; Okada A; Higuchi K Thromb Res; 2019 Apr; 176():74-78. PubMed ID: 30780007 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation. Morita N; Nakahara K; Morita R; Suetani K; Michikawa Y; Sato J; Tsuji K; Ikeda H; Matsunaga K; Watanabe T; Matsumoto N; Okuse C; Suzuki M; Itoh F Intern Med; 2019 Apr; 58(7):907-914. PubMed ID: 30449812 [TBL] [Abstract][Full Text] [Related]
9. Effect of Recombinant Human Soluble Thrombomodulin on Coagulation-Related Variables in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Retrospective Observational Study. Mitaka C; Kawagoe I; Satoh D; Hayashida M Clin Appl Thromb Hemost; 2021; 27():10760296211050356. PubMed ID: 34859680 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia. Ookura M; Hosono N; Tasaki T; Oiwa K; Fujita K; Ito K; Lee S; Matsuda Y; Morita M; Tai K; Negoro E; Kishi S; Iwasaki H; Ueda T; Yamauchi T Medicine (Baltimore); 2018 Nov; 97(44):e12981. PubMed ID: 30383650 [TBL] [Abstract][Full Text] [Related]
11. [The efficacy of early use of recombinant soluble thrombomodulin for disseminated intravascular coagulation complicated with hematologic malignancies]. Usami M; Kuroda H; Yoshida M; Sakamoto H; Shimoyama S; Kanari Y; Yamada M; Abe T; Fujii S; Maeda M Rinsho Ketsueki; 2015 Jun; 56(6):673-80. PubMed ID: 26256878 [TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors. Ouchi K; Takahashi S; Chikamatsu S; Ito S; Takahashi Y; Kawai S; Okita A; Kasahara Y; Okada Y; Imai H; Komine K; Saijo K; Takahashi M; Shirota H; Takahashi M; Gamoh M; Ishioka C Int J Clin Oncol; 2018 Aug; 23(4):790-798. PubMed ID: 29511940 [TBL] [Abstract][Full Text] [Related]
13. Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation. Suetani K; Okuse C; Nakahara K; Michikawa Y; Noguchi Y; Suzuki M; Morita R; Sato N; Kato M; Itoh F World J Gastroenterol; 2015 Jan; 21(2):533-40. PubMed ID: 25593469 [TBL] [Abstract][Full Text] [Related]
14. Impact of Recombinant Human Soluble Thrombomodulin for Disseminated Intravascular Coagulation. Itoh S; Shirabe K; Kohnoe S; Sadanaga N; Kajiyama K; Yamagata M; Anai H; Harimoto N; Ikegami T; Yoshizumi T; Maehara Y Anticancer Res; 2016 May; 36(5):2493-6. PubMed ID: 27127163 [TBL] [Abstract][Full Text] [Related]
15. A rare case of diffuse large B-cell lymphoma-associated hemophagocytic lymphohistiocytosis. Malkan UY; Albayrak M; Yildiz A; Maral S; Afacan Ozturk HB; Comert P J Oncol Pharm Pract; 2021 Jan; 27(1):250-252. PubMed ID: 32507098 [TBL] [Abstract][Full Text] [Related]
16. Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis. Okuda A; Ogura T; Imanishi M; Miyano A; Nishioka N; Higuchi K Gut Liver; 2018 Jul; 12(4):471-477. PubMed ID: 29699063 [TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseases. Kawano N; Tasaki A; Kuriyama T; Tahara Y; Yoshida S; Ono N; Himeji D; Yamashita K; Shibata Y; Goto T; Inoue T; Yokota-Ikeda N; Uezono S; Yuge A; Nishiguchi T; Kinjo T; Ogura Y; Beppu K; Ueda Y; Kinoshita M; Moritake H; Shimoda K; Ochiai H; Ueda A Intern Med; 2014; 53(3):205-13. PubMed ID: 24492688 [TBL] [Abstract][Full Text] [Related]
18. Clinical features and treatment of natural killer/T cell lymphoma associated with hemophagocytic syndrome: comparison with other T cell lymphoma associated with hemophagocytic syndrome. Han L; Li L; Wu J; Li X; Zhang L; Wang X; Fu X; Ma W; Sun Z; Zhang X; Chang Y; Guo S; Zhang M Leuk Lymphoma; 2014 Sep; 55(9):2048-55. PubMed ID: 24359240 [TBL] [Abstract][Full Text] [Related]
19. Generalized B-cell non Hodgkin's lymphoma in association with leukocytoclastic vasculitis and disseminated intravascular coagulation. Cardinali C; Santini S; di Leo A; Giannini A; Lo Scocco G Dermatol Online J; 2006 Mar; 12(3):15. PubMed ID: 16638429 [TBL] [Abstract][Full Text] [Related]
20. [Clinical Efficacy of Recombinant Human Thrombomodulin for Surgical Patients with Disseminated Intravascular Coagulation Associated with Oncologic Emergency]. Ikuta L; Nakajima T; Fujikawa M; Nomura K; Matsuki G; Ichise N; Kasai M; Okamoto R; Ikuta S; Nakamoto Y; Aihara T; Yanagi H; Yamanaka N Gan To Kagaku Ryoho; 2022 Dec; 49(13):1408-1410. PubMed ID: 36733084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]